Choosing a contract manufacturer is not a line item — it is the decision that determines whether your product is safe, consistent, compliant, and able to scale when demand grows. Brand owners often compare quotes side by side and treat manufacturers as interchangeable, but the differences between facilities show up later, in ways that are expensive to fix: inconsistent potency between batches, delayed launches because a formula could not actually be produced at scale, or a compliance gap that surfaces during a retailer audit. A structured due-diligence process up front prevents most of these problems.
Start with regulatory status, and ask for evidence rather than assurances. In the United States, dietary supplement manufacturers are expected to register their facility with the FDA and operate under current Good Manufacturing Practices (cGMP) as defined in 21 CFR Part 111. If a facility also produces or distributes into Mexico, it should be able to speak clearly about how it manages COFEPRIS expectations for the products and processes involved. Any credible manufacturer should be able to describe its registration status, its most recent internal or third-party audit findings, and how it handles corrective actions, without hesitation.
Next, look at the quality system itself, not just the certificate on the wall. Ask to see a sample Certificate of Analysis for both raw materials and finished goods, a batch record template, and documentation of how lot-to-lot traceability works from incoming ingredient to finished, packaged unit. Find out whether stability testing is standard practice for new formulas, how allergen and cross-contamination controls are structured, and whether HACCP principles are applied where relevant to the product type. A manufacturer that willingly walks you through these documents is signaling a mature quality culture; one that is vague or defensive is a warning sign.
Format and scope capability matter just as much as paperwork. A facility that lists capsules, tablets, powders, gummies, stick packs, functional beverages, patches, and oils on a capabilities sheet should be able to show actual production equipment and finished examples for each — not just a willingness to "figure it out." Ask specifically about formulation and R&D support: can the team take a bench-scale idea or a rough concept and turn it into a stable, manufacturable formula, or are you expected to arrive with a finished, production-ready specification?
Minimum order quantities and scalability deserve their own conversation. Understand the MOQ for your specific format, how long it realistically takes from finalized formula to first production run, and — critically — what happens when you succeed. Can the same facility handle a tenfold increase in order volume, additional SKUs, or a second format, or will growth force you to requalify a new manufacturer just as your brand is gaining traction? Switching manufacturers mid-growth is disruptive and risky; it is worth choosing a partner who can grow with you.
Packaging and fulfillment are frequently underestimated. Ask whether primary packaging (bottling, blistering, pouching), labeling, and fulfillment happen under the same roof or get handed off to a third party. Every handoff between vendors adds time, cost, and a point of potential error — a mislabeled case or a shipment that sits waiting for a separate facility to catch up. Fewer handoffs generally means tighter timelines and easier accountability.
For brands selling across the United States, Mexico, and the wider LATAM region, cross-border logistics is its own line of diligence. Ask how the manufacturer handles customs documentation, whether there is a distribution point on the US side that simplifies import compliance, and what lead times look like for shipments crossing the border in either direction. A manufacturer that regularly moves product across this specific corridor will have real answers, not estimates.
Finally, treat communication as a quality indicator in its own right. During the sales process, note how quickly and completely your questions get answered, whether the manufacturer proactively raises issues with your formula or label rather than waiting for you to catch them, and how change control works when you need to update a formula, packaging, or supplier later. The red flags to watch for are consistent: reluctance to share documentation, vague answers about registration status, no defined label-review process, or pressure to skip stability testing to hit a launch date.
Due diligence takes time up front, but it is far cheaper than a recall, a failed retailer audit, or a relaunch under a different manufacturer a year in. Approach the selection process as choosing a long-term operating partner, not a one-time vendor, and the rest of the launch tends to go more smoothly.
